Curcumin induces apoptosis-independent death in oesophageal cancer cells.
AffiliationLeslie C. Quick Laboratory, Cork Cancer Research Centre, BioSciences Institute,, University College Cork and Mercy University Hospital, Cork, Ireland.
Cell Cycle/drug effects
Cell Line, Tumor
Cell Survival/drug effects
Esophageal Neoplasms/*drug therapy/pathology
Proteasome Endopeptidase Complex/physiology
MetadataShow full item record
CitationBr J Cancer. 2009 Nov 3;101(9):1585-95. Epub 2009 Oct 6.
JournalBritish journal of cancer
AbstractBACKGROUND: Oesophageal cancer incidence is increasing and survival rates remain extremely poor. Natural agents with potential for chemoprevention include the phytochemical curcumin (diferuloylmethane). We have examined the effects of curcumin on a panel of oesophageal cancer cell lines. METHODS: MTT (3-(4,5-dimethyldiazol-2-yl)-2,5 diphenyl tetrazolium bromide) assays and propidium iodide staining were used to assess viability and DNA content, respectively. Mitotic catastrophe (MC), apoptosis and autophagy were defined by both morphological criteria and markers such as MPM-2, caspase 3 cleavage and monodansylcadaverine (MDC) staining. Cyclin B and poly-ubiquitinated proteins were assessed by western blotting. RESULTS: Curcumin treatment reduces viability of all cell lines within 24 h of treatment in a 5-50 muM range. Cytotoxicity is associated with accumulation in G2/M cell-cycle phases and distinct chromatin morphology, consistent with MC. Caspase-3 activation was detected in two out of four cell lines, but was a minor event. The addition of a caspase inhibitor zVAD had a marginal or no effect on cell viability, indicating predominance of a non-apoptotic form of cell death. In two cell lines, features of both MC and autophagy were apparent. Curcumin-responsive cells were found to accumulate poly-ubiquitinated proteins and cyclin B, consistent with a disturbance of the ubiquitin-proteasome system. This effect on a key cell-cycle checkpoint regulator may be responsible for the mitotic disturbances and consequent cytotoxicity of this drug. CONCLUSION: Curcumin can induce cell death by a mechanism that is not reliant on apoptosis induction, and thus represents a promising anticancer agent for prevention and treatment of oesophageal cancer.
- Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma.
- Authors: Koprowski S, Sokolowski K, Kunnimalaiyaan S, Gamblin TC, Kunnimalaiyaan M
- Issue date: 2015 Oct
- Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
- Authors: Zhao Z, Li C, Xi H, Gao Y, Xu D
- Issue date: 2015 Oct
- In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
- Authors: Sufi SA, Adigopula LN, Syed SB, Mukherjee V, Coumar MS, Rao HS, Rajagopalan R
- Issue date: 2017 Jan
- Curcumin analogue A501 induces G2/M arrest and apoptosis in non-small cell lung cancer cells.
- Authors: Xia YQ, Wei XY, Li WL, Kanchana K, Xu CC, Chen DH, Chou PH, Jin R, Wu JZ, Liang G
- Issue date: 2014
- Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells.
- Authors: Moragoda L, Jaszewski R, Majumdar AP
- Issue date: 2001 Mar-Apr